| Roderick T. Wong |
Roderick T. Wong founded RTW Investments LP. Currently, he holds the position of Chairman for Rocket Pharmaceuticals, Inc., Chairman, President & Chief Executive Officer for Health Sciences Acquisitions Corp. 2 and Managing Partner at RTW Investments LP, Managing Partner & Chief Investment Officer at RTW Investments (a subsidiary of RTW Investments LP). Dr. Wong is also on the board of Attune Pharmaceuticals, Inc. and NiKang Therapeutics, Inc.
He previously held the position of Principal at Davidson Kempner Capital Management LP and Chairman, President & Chief Executive Officer of Health Sciences Acquisitions Corp.
Roderick T. Wong received an undergraduate degree from Duke University, an MBA from Harvard Business School and a doctorate from Perelman School of Medicine. |
| Naveen Yalamanchi |
Presently, Naveen Yalamanchi is Chief Financial Officer, Director & Executive VP at Health Sciences Acquisitions Corp. 2 and Portfolio Manager at RTW Investments LP, Partner & Portfolio Manager at RTW Investments (a subsidiary of RTW Investments LP). Dr. Yalamanchi is also on the board of Ancora Heart, Inc., Magnolia Medical Technologies, Inc. and Rocket Pharmaceuticals, Inc.
Naveen Yalamanchi previously occupied the position of Analyst at Davidson Kempner Capital Management LP, Portfolio Manager at RTW Investments LP, Chief Financial Officer, Director & Executive VP at Health Sciences Acquisitions Corp., Analyst at Millennium Management LLC, Orthopedic Surgery Resident at UCLA Medical Center, Vice President & Co-Manager-Portfolio at Calamos Investments LLC and Head of Sector Research at Black Capital LLC.
He received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Stanford University School of Medicine. |
| Pedro P. Granadillo |
Founder of Umbria Pharmaceuticals, LLC and Neumentum, Inc., Pedro P. Granadillo is on the board of Umbria Pharmaceuticals, LLC, Rocket Pharmaceuticals, Inc. and Health Sciences Acquisitions Corp. 2. In the past he held the position of Chairman for Aura Biosciences, Inc., SVP-Global Manufacturing & Human Resources at Eli Lilly & Co. and Director at Neumentum, Inc.
Pedro P. Granadillo received an undergraduate degree from Purdue University. |
| Carsten Boess |
Carsten Boess founded Kiniksa Pharmaceuticals Ltd. Mr. Boess is on the board of Avidity Biosciences, Inc. and 4 other companies.
Mr. Boess previously was Vice President-International Operations at Insulet Corp., Vice President-Finance & International Operations at Novo Nordisk An and Manager-Investor Relations & Finance at Novo Nordisk North America, Inc. (a subsidiary of Novo Nordisk A), Senior Director-Finance & Information Technology at Novozymes A, Executive Vice President-Corporate Affairs at Kiniksa Pharmaceuticals Ltd., Chief Financial Officer of Alexion Pharmaceuticals, Inc., Executive Vice President-Finance at EMD Serono, Inc. and Chief Financial Officer & Senior Vice President for Synageva BioPharma Corp.
Mr. Boess received an undergraduate degree and a graduate degree from the University of Southern Denmark. |
| Stuart Walter Peltz |
Founder of PTC Therapeutics, Inc., Stuart Walter Peltz presently is Chief Executive Officer & Director at this company. Dr. Peltz is also on the board of BioNJ, Inc. (former Chairman), PTC Therapeutics International Ltd., Health Sciences Acquisitions Corp. 2 and PTC Therapeutics Ltd.
In the past Dr. Peltz occupied the position of Professor at the University of Medicine & Dentistry of New Jersey and Professor-Molecular Genetics & Microbiology at Robert Wood Johnson Medical School.
Stuart Walter Peltz received a doctorate from the University of Wisconsin. |
| Michael Burkes Brophy |
Presently, Michael Burkes Brophy holds the position of Chief Financial & Accounting Officer of Natera, Inc. He is also on the board of Health Sciences Acquisitions Corp. 2.
Mr. Brophy previously held the position of Executive Director at Morgan Stanley.
Mr. Brophy received an undergraduate degree from United States Air Force Academy and an MBA from the University of California, Los Angeles. |
